Microbiome modulation for performance and recovery
The afternoon sessions started with an in-depth look at the potential for microbiome modulation to impact athletic performance and recovery and featured a presentation by Dr. Alex Mohr, director of microbiomics at Theriome (second from right), about the emerging gut-muscle axis, and Carolina Barsa, co-founder and chief innovation and growth officer at Fitbiomics, on the company's probiotic Veillonella strain, a beneficial microbe that naturally eats lactic acid and converts it into short chain fatty acids to fight fatigue and promote endurance.
Dr. Mohr and Ms. Barsa then joined a panel discussion featuring Dr. Ralf Jäger, managing member at Increnovo (left) and moderated by NutraIngredients-USA's Stephen Daniells, on the wider potential of microbiome modulation in athletic populations, including improved immune health, protein utilization and the emerging field of postbiotics.
